GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

JBM (Healthcare) 2161.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

1.58

-1.86%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in HKD, from our data supplier.

FY2026

Revenue

HK$834.6m

FY2018FY2026

Net income

HK$201.1m

FY2018FY2026

Free cash flow

HK$119.4m

FY2018FY2026

Shareholders' equity

HK$1.08bn

FY2018FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueHK$834.6mHK$782.3mHK$648.4mHK$520.3mHK$406.1mHK$397.2mHK$381.5mHK$307.5mHK$264.3m
Gross profitHK$465.5mHK$413.7mHK$338.1mHK$187.9mHK$142.3mHK$180.9mHK$190.2mHK$169.7mHK$146.2m
Research and development———————HK$235,000HK$9,000
Operating incomeHK$253.7mHK$246.1mHK$174.2mHK$67.8mHK$36.4mHK$70.9mHK$51.8mHK$66.5mHK$53.6m
Net incomeHK$201.1mHK$197.3mHK$130.5mHK$57.1mHK$24.6mHK$22.6mHK$41.0mHK$52.5mHK$42.4m
Diluted earnings per share0.250.240.160.060.030.030.050.060.05

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsHK$1.76bnHK$1.55bnHK$1.39bnHK$1.40bnHK$1.33bnHK$1.38bnHK$1.37bnHK$1.29bnHK$1.13bn
Cash and short-term investmentsHK$119.9mHK$205.8mHK$140.8mHK$152.3mHK$69.8mHK$94.4mHK$72.8mHK$51.0mHK$56.9m
Total liabilitiesHK$631.6mHK$381.2mHK$366.8mHK$372.1mHK$363.3mHK$434.3mHK$653.5mHK$1.11bnHK$1.00bn
DebtHK$393.7mHK$171.7mHK$133.4mHK$180.1mHK$213.1mHK$267.9mHK$466.4mHK$12.6mHK$24.5m
Shareholders' equityHK$1.08bnHK$1.08bnHK$970.7mHK$985.5mHK$929.2mHK$904.7mHK$657.3mHK$147.6mHK$97.2m
Shares outstanding819m815m824m909m893m894m894m819m819m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operationsHK$152.7mHK$226.9mHK$191.2mHK$145.9mHK$60.0mHK$58.9mHK$38.3mHK$56.9mHK$82.3m
Capital spending−HK$33.3m−HK$21.0m−HK$10.2m−HK$8.1m−HK$7.1m−HK$23.0m−HK$4.5m−HK$9.1m−HK$10.6m
Free cash flowHK$119.4mHK$205.9mHK$181.0mHK$137.8mHK$53.0mHK$36.0mHK$33.8mHK$47.8mHK$71.7m
Dividends paid−HK$173.8m−HK$78.7m−HK$52.7m−HK$4.5m−HK$4.5m−HK$4.5m−HK$4.5m——

Latest quarters

By quarter end

Mar 2026Sept 2025Mar 2025Sept 2024Mar 2024Sept 2023Mar 2023Sept 2022
RevenueHK$405.0mHK$429.6mHK$383.3mHK$399.0mHK$321.6mHK$326.8mHK$283.5mHK$236.8m
Gross profitHK$211.9mHK$253.6mHK$207.8mHK$205.9mHK$167.0mHK$171.1mHK$120.0mHK$85.5m
Operating incomeHK$111.7mHK$150.6mHK$116.0mHK$121.6mHK$88.4mHK$78.9mHK$41.9mHK$25.9m
Net incomeHK$86.1mHK$115.0mHK$101.4mHK$95.9mHK$68.0mHK$62.5mHK$35.5mHK$21.6m
Diluted earnings per share0.110.140.120.120.080.070.040.02
Cash from operationsHK$63.0mHK$91.0mHK$96.0mHK$130.0mHK$131.0mHK$60.0mHK$83.0mHK$61.0m
Capital spending−HK$17.0m−HK$15.0m−HK$14.0m−HK$6.0m—−HK$9.0m−HK$4.0m−HK$3.0m
Free cash flowHK$46.0mHK$76.0mHK$82.0mHK$124.0m—HK$51.0mHK$79.0mHK$58.0m
Total assetsHK$1.76bnHK$1.77bnHK$1.55bnHK$1.41bnHK$1.39bnHK$1.43bnHK$1.40bnHK$1.34bn
Cash and short-term investmentsHK$119.9mHK$194.2mHK$205.8mHK$189.7mHK$140.8mHK$114.2mHK$152.3mHK$94.7m
DebtHK$384.5mHK$374.4mHK$171.7mHK$82.1mHK$133.4mHK$144.7mHK$180.1mHK$189.5m
Shareholders' equityHK$1.08bnHK$1.07bnHK$1.08bnHK$1.01bnHK$970.7mHK$1.00bnHK$985.5mHK$941.3m

Financial ratios

Data as of 29 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2019FY2018
Gross margin55.8%52.9%52.1%36.1%35.0%45.6%——
Operating margin30.4%31.5%26.9%13.0%9.0%17.9%——
Net margin24.1%25.2%20.1%11.0%6.1%5.7%——
Return on equity18.6%18.2%13.4%5.8%2.6%2.5%——
Return on assets11.4%12.8%9.4%4.1%1.8%1.6%——
Free cash flow yield14.1%18.9%15.2%10.5%4.7%5.7%——
Revenue growth6.7%20.6%24.6%28.1%2.3%4.1%——
Earnings growth1.9%51.2%128.5%131.9%8.9%-44.9%——
Current ratio1.90x1.61x1.66x1.70x2.06x2.07x——
Debt to equity0.36x0.15x0.13x0.17x0.21x0.27x——
Equity ratio61.3%70.0%69.9%70.2%69.7%65.5%——
Interest coverage21.71x55.14x20.50x8.26x5.68x9.57x——
R&D as a share of sales——————0.1%0.0%
Buybacks as a share of market value-0.5%1.2%9.3%-1.8%0.1%0.0%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue17.9%16.1%—
Operating income55.3%29.0%—
Net income52.1%54.8%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin54.4%50.4%48.2%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Price to earnings6.811.012.016.734.540.7
Price to sales1.72.82.51.92.12.4

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 7 Sept 2026.

FY2027FY2026FY2025FY2024FY2023
Paid in the year0.0740.2130.0960.060.005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.